Jubilant Pharma Develops Oral Formulation of Remdesivir
On Monday, Jubilant Pharma announced that it has developed a novel oral formulation of Remdesivir, which, the company said, is likely to ease the capacity...
Tag : Jubilant Pharma
Jubilant Life Sciences Considering CapEx Of Rs. 550 crores
Indian pharmaceutical company Jubilant Life Sciences has said in a statement that the company has designated Rs. 550 crores for the capital expenditure (CapEx) for...
Jubilant Life receives USFDA approval for hypertension drug
The US health regulator has provided its final approval to Jubilant Life Sciences for olmesartan medoxomil tablets that are used in treating of hypertension. The...
Jubilant Pharma has raised $300 million through bonds
Jubilant Pharma, the subsidiary of Jubilant Life Science, has raised USD 300 million (approx Rs 1,998 crore) through issuing five year bonds to mainly retire...